AIZBuy
Assurant
Price (1y)
Fair price check
4 different valuation methods each estimate what AIZ should be worth, then we compare to today's price.
- P/E multiplesUndervaluedthinks it's a bargain — estimates $450.58, about 77% above today
- P/B multiplesFairthinks it's fairly priced — estimates $235.57, about 7% below today
- Graham (defensive)Overvaluedthinks it's expensive — estimates $133.18, about 48% below today
- Residual IncomeOvervaluedthinks it's expensive — estimates $66.30, about 74% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
| Method | Value |
|---|---|
| Graham (defensive) | $133.18 |
| P/E multiples(vs sector peers) | $450.58 |
| P/B multiples(vs sector peers) | $235.57 |
| EV/EBITDA | skipped |
| Residual Income | $66.30 |
| DCF (2-stage) | skipped |
- goodwill heavy
Median of all applicable methods (current price $254.61). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Pillar breakdown
8 dimensions, each scored 0–100 against the universe
- QualityProfit margins & asset efficiency67Decent
- ValuePrice vs fundamentals66Decent
- GrowthRevenue & earnings trajectory80Strong
- MomentumRecent price strength65Decent
- HealthBalance sheet & solvency53Decent
- ProfitabilityROE, ROA, ROIC48Weak
- TechnicalTrend & volatility signals68Decent
- RiskVolatility & drawdown profile68Decent
Pillars not shown: Sentiment, ML (Phase 5+).
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $12.62B |
| Revenue (TTM) | $13.16B |
| Net income (TTM) | $1.62B |
| Operating cash flow (TTM) | $1.68B |
| CapEx (TTM) | $229.80M |
| Free cash flow (TTM)CFO − CapEx | $1.45B |
| Total assets | $35.77B |
| Total liabilities | $29.90B |
| Stockholders' equity | $5.87B |
| Cash & equivalents | $1.59B |
| Shares outstanding | 49.55M |
| EPS (basic) | $5.47 |
| EPS (diluted) | $5.41 |
| P/E ratio (TTM) | 7.80 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-05-07
- Latest period end
- 2026-05-01
- Filing lag
- 9 days
- Missing metrics
- 13(gross_profit, operating_income, cost_of_revenue, research_and_development, sga_expense, depreciation_and_amortization, current_assets, current_liabilities, inventory, accounts_receivable, accounts_payable, short_term_debt, ebitda)
Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.